CYP2C9 polymorphism and warfarin dose requirements

被引：21

作者：

Daly, AK

Day, CP

Aithal, GP

机构：

[1] Univ Newcastle Upon Tyne, Sch Med, Dept Pharmacol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[2] Univ Newcastle Upon Tyne, Sch Med, Liver Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England

[3] Univ Hosp, Queens Med Ctr, Nottingham NG7 2UH, England

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 53卷 / 04期

关键词：

D O I：

10.1046/j.1365-2125.2002.01572_6.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：408 / 409

页数：2

共 10 条

[1] Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].

Aithal, GP ;

Day, CP ;

Kesteven, PJL ;

Daly, AK .

LANCET, 1999, 353 (9154) :717-719

[2]

Aynacioglu AS, 1999, BRIT J CLIN PHARMACO, V48, P409

[3] The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase [J].

Crespi, CL ;

Miller, VP .

PHARMACOGENETICS, 1997, 7 (03) :203-210

[4] Clinical relevance of genetic polymorphisms in the human CYP2C subfamily [J].

Goldstein, JA .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) :349-355

[5]

KAMINSKY LS, 1993, MOL PHARMACOL, V43, P234

[6] IMPAIRED (S)-WARFARIN METABOLISM CATALYZED BY THE R144C ALLELIC VARIANT OF CYP2C9 [J].

RETTIE, AE ;

WIENKERS, LC ;

GONZALEZ, FJ ;

TRAGER, WF ;

KORZEKWA, KR .

PHARMACOGENETICS, 1994, 4 (01) :39-42

[7] Genetic analysis of the human cytochrome P450 CYP2C9 locus [J].

Stubbins, MJ ;

Harries, LW ;

Smith, G ;

Tarbit, MH ;

Wolf, CR .

PHARMACOGENETICS, 1996, 6 (05) :429-439

[8] Influence of cytochrome P-450CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment [J].

Taube, J ;

Halsall, D ;

Baglin, T .

BLOOD, 2000, 96 (05) :1816-1819

[9] DETECTION OF CYP2C9 POLYMORPHISM BASED ON THE POLYMERASE CHAIN-REACTION IN CHINESE [J].

WANG, SL ;

HUANG, JD ;

LAI, MD ;

TSAI, JJ .

PHARMACOGENETICS, 1995, 5 (01) :37-42

[10] Validation of methods for CYP2C9 genotyping:: Frequencies of mutant alleles in a Swedish population [J].

Yasar, Ü ;

Eliasson, E ;

Dahl, ML ;

Johansson, I ;

Ingelman-Sundberg, M ;

Sjoqvist, F .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (03) :628-631

← 1 →